Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation

Journal of Immunology

Volumn 175, Issue 4, 2005, Pages 2589-2597

  Gueders, Maud M ^a   Balbin, Milagros ^b   Rocks, Natacha ^a   Foidart, Jean Michel ^a   Gosset, Philippe ^c   Louis, Renaud ^a   Shapiro, Steven ^d   Lopez Otin, Carlos ^b   Noël, Agnes ^a   Cataldo, Didier D ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c INSERM   (France)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN E; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; MACROPHAGE ELASTASE; MACROPHAGE INFLAMMATORY PROTEIN 2; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; OVALBUMIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CYTOKINE PRODUCTION; ENZYME DEFICIENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; GRANULOCYTE; HISTOPATHOLOGY; INFLAMMATION; INFLAMMATORY INFILTRATE; LUNG LAVAGE; MOUSE; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 23444445054     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.4.2589     Document Type: Article

References (42)

1. 2003. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur. Respir. J. 22: 470-477.
2. Lamblin, C., P. Gosset, I. Tillie-Leblond, F. Saulnier, C. H. Marquette, B. Wallaert, and A. B. Tonnel. 1998. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am. J. Respir. Crit. Care Med. 157: 394-402.
3. Anticevich, S. Z., J. M. Hughes, J. L. Black, and C. L. Armour. 1996. Induction of hyperresponsiveness in human airway tissue by neutrophils: mechanism of action. Clin. Exp. Allergy 26: 549-556.
4. Paggiaro, P. L., F. L. Dente, A. Azzara, L. Bancalari, P. Bernard, E. Bacci, M. Carrara, A. Di Franco, D. Giannini, and B. Vagaggini. 1993. Abnormal migratory activity of peripheral neutrophils from asthmatic patients and its modulation by inhaled glucocorticoids. J. Invest. Allergol. Clin. Immunol. 3: 237-244.
5. Bousquet, J., P. Chanez, J. Y. Lacoste, R. White, P. Vie, P. Godard, and F. B. Michel. 1992. Asthma: a disease remodeling the airways. Allergy 47: 3-11.
6. Roche, W. R., R. Beasley, J. H. Williams, and S. T. Holgate. 1989. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1: 520-524.
7. Egeblad, M., and Z. Werb. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2: 161-174.
8. Overall, C. M., and C. Lopez-Otin. 2002. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat. Rev. Cancer 2: 657-672.
9. Brinckerhoff, C. E., and L. M. Matrisian. 2002. Timeline: Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell Biol. 3: 207-214.
10. Zucker, S., D. Q. Pei, J. Cao, and C. Lopez-Otin. 2003. Membrane type-matrix metalloproteinases (MT-MMP). Curr. Top. Dev. Biol. 54: 1-74.
11. Woessner, J., and H. Nagase. 2004. Matrix Metalloproteinases and TIMPs. Oxford University Press, Oxford.
12. Holmbeck, K., P. Bianco, J. Caterina, S. Yamada, M. Kromer, S. A. Kuznetsov, M. Mankani, P. G. Robey, A. R. Poole, I. Pidoux, et al. 1999. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99: 81-92.
13. Hotary, K., E. Allen, A. Punturieri, I. Yana, and S. J. Weiss. 2000. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J. Cell Biol. 149: 1309-1323.
14. Cataldo, D., C. Munaut, A. Noel, F. Frankenne, P. Bartsch, J. M. Foidart, and R. Louis. 2000. MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int. Arch. Allergy Immunol. 123: 259-267.
15. Cataldo, D. D., M. Gueders, C. Munaut, N. Rocks, P. Bartsch, J. M. Foidart, A. Noel, and R. Louis. 2004. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases mRNA transcripts in the bronchial secretions of asthmatics. Lab. Invest. 84: 418-424.
16. Mautino, G., N. Oliver, P. Chanez, J. Bousquet, and F. Capony. 1997. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am. J. Respir. Cell Mol. Biol. 17: 583-591.
17. Cataldo, D., C. Munaut, A. Noel, F. Frankenne, P. Bartsch, J. M. Foidart, and R. Louis. 2001. Matrix metalloproteinases and TTMP-1 production by peripheral blood granulocytes from COPD patients and asthmatics. Allergy 56: 145-151.
18. Ding, Y., V. J. Uitto, M. Haapasalo, K. Lounatmaa, Y. T. Konttinen, T. Salo, D. Grenier, and T. Sorsa. 1996. Membrane components of Treponema denticola trigger proteinase release from human polymorphonuclear leukocytes. J. Dent. Res. 75: 1986-1993.
19. Hasty, K. A., M. S. Hibbs, A. H. Rang, and C. L. Mainardi. 1986. Secreted forms of human neutrophil collagenase. J. Biol. Chem. 261: 5645-5650.
20. Murphy, G., J. J. Reynolds, U. Bretz, and M. Baggiolini. 1977. Collagenase is a component of the specific granules of human neutrophil leukocytes. Biochem. J. 162: 195-197.
21. Owen, C. A., Z. Hu, C. Lopez-Otin, and S. D. Shapiro. 2004. Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase. J. Immunol. 172: 7791-7803.
22. Prikk, K., P. Maisi, E. Pirila, R. Sepper, T. Salo, J. Wahlgren, and T. Sorsa. 2001. In vivo collagenase-2 (MMP-8) expression by human bronchial epithelial cells and monocytes/macrophages in bronchiectasis. J. Pathol. 194: 232-238.
23. Sepper, R., Y. T. Konttinen, Y. Ding, M. Takagi, and T. Sorsa. 1995. Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease. Chest 107: 1641-1647.
24. Prikk, K., P. Maisi, E. Pirila, M. A. Reintam, T. Salo, T. Sorsa, and R. Sepper. 2002. Airway obstruction correlates with collagenase-2 (MMP-8) expression and activation in bronchial asthma. Lab. Invest. 82: 1535-1545.
25. Balbin, M., A. Fueyo, A. M. Tester, A. M. Pendas, A. S. Pitiot, A. Astudillo, C. M. Overall, S. D. Shapiro, and C. Lopez-Otin. 2003. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat. Genet. 35: 252-257.
26. Hasty, K. A., J. J. Jeffrey, M. S. Hibbs, and H. G. Welgus. 1987. The collagen substrate specificity of human neutrophil collagenase. J. Biol. Chem. 262: 10048-10052.
27. Michaelis, J., M. C. Vissers, and C. C. Winterbourn. 1990. Human neutrophil collagenase cleaves α1-antitrypsin. Biochem. J. 270: 809-814.
28. Weiss, S. J. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320: 365-376.
29. Montel, V., J. Kleeman, D. Agarwal, D. Spinella, K. Kawai, and D. Tarin. 2004. Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression. Cancer Res. 64: 1687-1694.
30. Cataldo, D. D., K. G. Tournoy, K. Vermaelen, C. Munaut, J. M. Foidart, R. Louis, A. Noel, and R. A. Pauwels. 2002. Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. Am. J. Pathol. 161: 491-498.
31. Lamblin, C., P. Gosset, I. Tillie-Leblond, F. Saulnier, C. H. Marquette, B. Wallaert, and A. B. Tonnel. 1998. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am. J. Respir. Crit. Care Med. 157: 394-402.
32. Betsuyaku, T., M. Nishimura, K. Takeyabu, M. Tanino, P. Venge, S. Xu, and Y. Kawakami. 1999. Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am. J. Respir. Crit. Care Med. 159: 1985-1991.
33. Henderson, W. R., Jr., L. O. Tang, S. J. Chu, S. M. Tsao, G. K. Chiang, F. Jones, M. Jonas, C. Pae, H. Wang, and E. Y. Chi. 2002. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am. J. Respir. Crit. Care Med. 165: 108-116.
34. Johnson, S., and A. Knox. 1999. Autocrine production of matrix metalloproteinase-2 is required for human airway smooth muscle proliferation. Am. J. Physiol. 277:L1109-L1117.
35. Van Den Steen, P. E., A. Wuyts, S. J. Husson, P. Proost, J. Van Damme, and G. Opdenakker. 2003. Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur. J. Biochem. 270: 3739-3749.
36. Girard, D., R. Paquin, and A. D. Beaulieu. 1997. Responsiveness of human neutrophils to interleukin-4: induction of cytoskeletal rearrangements, de novo protein synthesis and delay of apoptosis. Biochem. J. 325: 147-153.
37. Meyer-Hoffert, U., D. Lezcano-Meza, J. Bartels, A. R. Montes-Vizuet, J. M. Schroder, and L. M. Teran. 2003. Th2- and to a lesser extent Th1-type cytokines up-regulate the production of both CXC (IL-8 and Gro-α) and CC (RANTES, eotaxin, eotaxin-2, MCP-3 and MCP-4) chemokines in human airway epithelial cells. Int. Arch. Allergy Immunol. 131: 264-271.
38. Fukuda, T., Y. Fukushima, T. Numao, N. Ando, M. Arima, H. Nakajima, H. Sagara, T. Adachi, S. Motojima, and S. Makino. 1996. Role of interleukin-4 and vascular cell adhesion molecule-1 in selective eosinophil migration into the airways in allergic asthma. Am. J. Respir. Cell Mol. Biol. 14: 84-94.
39. Gounni, A. S., B. Lamkhioued, L. Koussih, C. Ra, P. M. Renzi, and Q. Hamid. 2001. Human neutrophils express the high-affinity receptor for immunoglobulin E (FcεRI): role in asthma. FASEB J. 15: 940-949.
40. McMillan, S. J., J. Kearley, J. D. Campbell, X. W. Zhu, K. Y. Larbi, J. M. Shipley, R. M. Senior, S. Nourshargh, and C. M. Lloyd. 2004. Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J. Immunol. 172: 2586-2594.
41. Cataldo, D. D., J. Bettiol, A. Noel, P. Bartsch, J. M. Foidart, and R. Louis. 2002. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest 122: 1553-1559.
42. Corry, D. B., K. Rishi, J. Kanellis, A. Kiss, Lz. L. Z. Song, J. Xu, L. Feng, Z. Werb, and F. Kheradmand. 2002. Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2 deficiency. Nat. Immunol. 3: 347-353.